Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial. Swiss Medical Weekly, [S. l.], v. 154, n. 4, p. 3762, 2024. DOI: 10.57187/s.3762. Disponível em: https://smw.ch/index.php/smw/article/view/3762. Acesso em: 14 oct. 2025.